Everything by Trey.

Investing

HP, Intel, and Xerox Are All Chasing the Same Comeback. History Says Only One Survives

Jun 29, 2026 Investing

Magic Formula Showdown: Why CVS Beats Qualcomm and Valero for Retirees

Jun 29, 2026 Investing

The Antonio Filosa Report Card: Grading Stellantis’ CEO After 1 Year

Jun 27, 2026 Investing

The Case for Holding VT in Your Roth IRA

Jun 26, 2026 Investing

The Greenblatt Magic Formula: How H&R Block, Molina, and Peabody Stack Up for Retirement Investors

Jun 26, 2026 Investing

BlackBerry, IBM, and Nokia Are All Trying to Come Back. History Says Only One Survives

Jun 26, 2026 Investing

Apple vs Microsoft: Which Is the Better Dip Buy Right Now?

Jun 26, 2026 Investing

The Case for Holding QQQM in a Roth IRA

Jun 25, 2026 Investing

After Tepper, Icahn, and Druckenmiller Dumped These 3 Stocks, They Kept Climbing. Time to Sell?

Jun 25, 2026 Investing

3 Under-the-Radar Biotech Takeover Targets for the Next Pharma Buying Spree

Jun 25, 2026 Investing

Netflix’s Next Act: Beyond Streaming

Jun 25, 2026 Investing

SoFi Bets on Innovation and Scale While Ally Prioritizes Dividends and Auto Lending Discipline

Jun 24, 2026 Investing

Stanley Druckenmiller Backs These 3 AI Infrastructure Stocks: Should You Follow?

Jun 24, 2026 Investing

The Beaten-Down Stock Wall Street Insiders Are Quietly Loading Up On

Jun 24, 2026 Investing

After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching

Jun 24, 2026 Investing

Reddit Loves Celsius, Chewy, and Estée Lauder. Does Wall Street Agree?

Jun 24, 2026 Investing

The Roth IRA Trick That Makes This Gold ETF’s 135% Five-Year Run Even Better

Jun 23, 2026 Investing

If You Had Invested $1,000 in MARA or Strategy a Decade Ago

Jun 23, 2026 Investing

Stanley Druckenmiller Backs These 3 Chip and Tech Stocks: Should You Follow?

Jun 23, 2026 Investing

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

Jun 23, 2026